Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Preoperative Cognitive Screening in Older Spinal Surgical Patients

30 juni 2021 uppdaterad av: Deborah Culley, MD, Brigham and Women's Hospital

Preoperative Cognitive Screening in Older Spinal Surgical Patients: Feasibility and Utility for Predicting Morbidity

The objectives of this study are to determine whether identifying patients with baseline cognitive deficits or frailty predict postoperative delirium.

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

This project is designed as a prospective, single-center observational study. The cohort will consist of 229 consenting subjects ≥ 70 years of age who present to the Brigham and Women's Hospital Weiner Center for Preoperative Evaluation (CPE) prior to elective spine surgery. These ages are chosen as significant clinical data demonstrate increased cognitive impairment in community dwelling elders. Eligibility criteria include: patients ≥ 70 years of age with an American Society of Anesthesiologists (ASA) physical status classification of I-III presenting for elective spine surgery. Exclusion criteria will include planned Intensive Care Unit (ICU) admission postoperatively, history of stroke or brain tumor, uncorrected vision or hearing impairment (unable to see pictures or read or hear instructions); limited use of the dominant hand (limited ability to draw); and or inability to speak, read, or understand English.

Patients will be introduced to the study through a flyer provided to them in their surgeon's office. A study team member will speak with those favorably predisposed to participate to determine if they satisfy eligibility criteria. After obtaining consent, study staff will gain information about the patient's age and years of education. Study staff will administer Health and functional status activities of daily living (ADLs) and instrumental activities of daily living (IADLs), respectively, and the World Health Organization Disability Assessment Scale [WHODAS]) will be administered to all surgical patients. The World Health Organization Disability Assessment Schedule 2.0 is an alternative to the 36-Item Rand Health Survey Short-Form (SF36) to measure physical health and disability. In addition, all patients will be asked if they've had a fall within the last 6 months, whether they've been evaluated for a change in memory or thinking, who accompanied them to their appointment, their employment status and their living situation (alone, institutionalized, living with family members) in a patient survey. The study staff will administer the MiniCog, a simple cognitive screening tool that takes just 2-4 min to complete and has little or no education, language, or race bias. In addition, the Animal Fluency test will be administered, which is a short cognitive screen that takes one minute to complete. Frailty will be measured using the Frail Scale. Other measures of cognitive impairment will be obtained by study staff through: documentation on the patient's standard preoperative form, patient or informant report of diagnosis or evaluation for cognitive impairment or memory concerns, and systematic medical record review. Each enrolled patient will receive a business card listing the investigators' contact information and be advised to expect a follow up telephone up to 6 and 12 months after surgery to verify data elements and reassess functional outcome.

Delirium will be assessed prospectively once per day on postoperative days 1, 2, and 3 if the patient remains hospitalized, by a trained study team member using the Confusion Assessment Method [CAM]. For patients that are in the Intensive Care Unit (ICU) postoperatively, the Confusion Assessment Method for the ICU (CAM-ICU) will be administered prospectively twice per day on postoperative days 1, 2, and 3 if the patient remains hospitalized by a trained study team member (Attachment-CAM-ICU). Delirium is most common on postoperative days 1-3 and the CAM is a well-validated measure of delirium in surgical patients. For functional status, the WHODAS will be administered 6-12 months postoperatively either by personnel in the surgeon's office as part of routine follow up or by study staff or by telephone. We will also collect information on secondary outcomes including discharge to place other than home (rehabilitation, skilled nursing facility), hospital length of stay (LOS), 30-day reoperation or readmission rate, and 30-day mortality. These outcomes are recorded in the medical record, the BWH Balanced Scorecard, an electronic database of all hospitalized patients that tabulates 31 elements of the hospital event, or the Brigham and Women's Hospital BWH Research Patient Database Enhanced Query. Data will also be confirmed by a follow up telephone interview.

Studietyp

Observationell

Inskrivning (Faktisk)

229

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02115
        • Weiner Center for Preoperative Evaluation

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

70 år och äldre (Äldre vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

229 consenting subjects ≥ 70 years of age who present to the BWH Weiner Center for Preoperative Evaluation (CPE) prior to elective spine surgery.

Beskrivning

Inclusion Criteria:

  • patients 70 years of age and older presenting to the BWH Weiner Center for Preoperative Evaluation
  • undergoing elective spine surgery

Exclusion Criteria:

  • include planned ICU admission postoperatively
  • history of stroke or brain tumor
  • uncorrected vision or hearing impairment (unable to see pictures or read or hear instructions)
  • limited use of the dominant hand (limited ability to draw)
  • inability to speak, read, or understand English.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
older surgical patients
Older surgical patients presenting for elective spine surgery
short cognitive screen, short Frailty screen
Andra namn:
  • Frailty
  • Animal Fluency

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Delirium by Age
Tidsram: up to 3 days post-op
The median ages of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method. The Confusion Assessment Method (CAM) is a short diagnostic interview for CAM-defined delirium. Delirium is defined as the sudden change in someone's thinking ability that can have devastating consequences and can be very easily missed due to its frequent subtlety. The 4 CAM features assessed by the CAM include: acute onset or fluctuation, inattention, disorganized thinking, or altered level of consciousness.
up to 3 days post-op
Number of Participants With or Without Delirium by Sex
Tidsram: up to 3 days post-op
Sex of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
up to 3 days post-op
Delirium by Body Mass Index
Tidsram: up to 3 days post-op
Median body mass index of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
up to 3 days post-op
Number of Participants With or Without Delirium by College Degree
Tidsram: up to 3 days post-op
Counts of patients with a college degree who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
up to 3 days post-op
Participants With an ASA Physical Status Score and the Development of Postoperative Delirium
Tidsram: up to 3 days post-op
The ASA Physical Status Classification System assesses and communicates a patient's pre-anesthesia medical co-morbidities and is on a scale of I-VI. This study recruited patients with an ASA physical status of I-III. ASA I is defined as a normal healthy patient, ASA II is defined as a patient with a mild systemic disease, ASA III is defined as a patient with severe systemic disease. ASA physical status of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
up to 3 days post-op
Number of Participants With or Without Delirium by Metabolic Equivalent of Task Score < 4
Tidsram: up to 3 days post-op
Patients with a metabolic equivalent of task (METS) score < 4 who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method. The METS score is a ratio of the working metabolic rate relative to the resting metabolic rate and is one way to describe the intensity of an exercise or activity. This was assessed by the preoperative or surgical study staff. A score of < 3 is for light intesity activities, 3-6 for moderate intensity activities, and ≥ 6 for vigorous intensity activities.
up to 3 days post-op
Delirium by Total Number of Medications Taken at Baseline
Tidsram: up to 3 days post-op
Median total number of medications of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
up to 3 days post-op
Number of Participants With or Without Delirium by Opioid Use
Tidsram: up to 3 days post-op
Patients with chronic use of opioids who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
up to 3 days post-op
Number of Participants With or Without Delirium by Alcohol Consumption
Tidsram: up to 3 days post-op
Patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method based on alcohol consumption.
up to 3 days post-op
Number of Participants With or Without Delirium by Presence of Depression
Tidsram: up to 3 days post-op
Patients with depression who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.
up to 3 days post-op
Number of Participants With or Without Delirium by Psychiatric History
Tidsram: up to 3 days post-op
Patients with a history of psychiatric disorders who did or did not develop post-operative delirium as assessed by the confusion assessment method.
up to 3 days post-op
Delirium by Mini-cog Score
Tidsram: up to 3 days post-op
Median mini-cog score of patients who did or did not develop post-operative delirium as assessed by the confusion assessment method. The Mini-Cog is a brief cognitive screening test for visuospatial representation, recall, and executive function. The test involves that includes recalling three words (banana, sunrise, and chair) and a clock drawing. The Mini-Cog has a scale from 0 to 5, a with higher scores suggesting better cognitive performance. One point is designated for each of 3 words recalled and up to two points for the clock drawing component.
up to 3 days post-op
Number of Participants With or Without Delirium by FRAIL Score
Tidsram: up to 3 days post-op
Robust, pre-frail, and frail patients who did or did not develop post-operative delirium as assessed by the confusion assessment method.
up to 3 days post-op
Number of Participants With or Without Delirium by Surgical Invasivness
Tidsram: up to 3 days post-op
Surgical invasiveness for patients who did or did not develop post-operative delirium as assessed by the confusion assessment method. The levels of invasiveness were categorized clinically as the following: Tier 1 for microdiscectomy, Tier 2 for lumbar laminectomy, anterior cervical, minimally invasive, foraminotomy, facetectomy, Tier 3 for lumbar fusion, trauma, and post-cervical, and Tier 4 for tumor, infection, deformity, and anterior and posterior cervical. Higher tiers indicate greater levels of invasiveness. Since there were very few patients with an invasiveness of 1 or 4 they were placed into two groups, with invasiveness levels I and 2 or 3 and 4.
up to 3 days post-op

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Number of Participants With In-hospital Complications Were Observed During Their Length of Stay in the Hospital With Death Postoperative Death Monitored up to Day 30.
Tidsram: duration of hospital stay, up to 30 days
In hospital complications after the surgical procedure including: Myocardial Infarction, congestive heart failure (CHF), Cardiac Arrest, Arrythmia, Pneumonia, pulmonary embolism (PE), Reintubation, Stroke, Delirium, Coma>24h, deep wound infection,Superficial wound infection, Sepsis, Renal Failure, urinary tract infection (UTI), Reoperation, deep vein thrombosis (DVT), intensive care unit (ICU) admission,
duration of hospital stay, up to 30 days
Participants' Discharge Location (Home vs. Other Than Home)
Tidsram: up to 30 days after the surgical procedure
Location where patients were discharged (Home vs other than home) on the day of patients discharge from the hospital.
up to 30 days after the surgical procedure

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Deborah Culley, M.D., Brigham and Women's Hospital

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

17 april 2017

Primärt slutförande (Faktisk)

9 oktober 2018

Avslutad studie (Faktisk)

9 juni 2019

Studieregistreringsdatum

Först inskickad

14 mars 2016

Först inskickad som uppfyllde QC-kriterierna

3 oktober 2016

Första postat (Uppskatta)

4 oktober 2016

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

21 juli 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

30 juni 2021

Senast verifierad

1 juni 2021

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Kognitiv försämring

Kliniska prövningar på Mini Cog

3
Prenumerera